Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Pluripotent stem cells (PSCs) represent an appealing source from which to develop cell replacement therapies. Different initiatives have been launched to promote their development toward clinical applications. This article will review the main questions that should be considered before translating P...
Main Authors: | Hulot, Jean-Sébastien, Stillitano, Francesca, Salem, Joe Elie, Kovacic, Jason C, Fuster, Valentin, Hajjar, Roger J |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055070/ |
Similar Items
-
Effectiveness of gene delivery systems for pluripotent and differentiated cells
by: Rapti, Kleopatra, et al.
Published: (2015) -
Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
by: Ng, Kwong-Man, et al.
Published: (2014) -
Automated electrophysiological and pharmacological evaluation of human pluripotent stem cell-derived cardiomyocytes
by: Rajamohan, Divya, et al.
Published: (2016) -
Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Lee, Yee-Ki, et al.
Published: (2011) -
Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes
by: Liu, Jianwei, et al.
Published: (2012)